Similar articles

• [Immunosuppressive acidic protein (IAP)].

  Fukazawa H, Yoshida K, Sakurada T. Fukazawa H, et al. Nihon Rinsho. 2010 Jul;68 Suppl 7:756-8. Nihon Rinsho. 2010. PMID: 20960865 Japanese. No abstract available.
• [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].

  Yamazaki K, Kumamoto Y, Tsukamoto T, Ohmura K, Miyao N, Yoshioka M, Iwasawa A. Yamazaki K, et al. Hinyokika Kiyo. 1991 May;37(5):467-74. Hinyokika Kiyo. 1991. PMID: 1858580 Japanese.
• [Immunosuppressive acid protein (IAP)].

  Ikeda H. Ikeda H. Nihon Rinsho. 2005 Aug;63 Suppl 8:711-2. Nihon Rinsho. 2005. PMID: 16149619 Review. Japanese. No abstract available.
• [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].

  Sato T, Sakata Y, Tamura K. Sato T, et al. Rinsho Byori. 1990 Mar;38(3):255-9. Rinsho Byori. 1990. PMID: 2190023 Review. Japanese.
• Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.

  Araki K, Igarashi T, Tobe T, Mizoguchi K, Suzuki H, Furuya Y, Ichikawa T, Nakatsu HO, Ito H. Araki K, et al. Urology. 2006 Dec;68(6):1178-82. doi: 10.1016/j.urology.2006.08.1071. Epub 2006 Dec 4. Urology. 2006. PMID: 17141843